Join Nikki Whitfield, VP, CDMO Services at Quotient Sciences and Claire Thompson, CEO, Agility Health Tech and discover how to transition from your candidate selection process and how to utilize a data driven approach to develop the right dosage forms to achieve proof-of-concept.
This webinar will explore screening techniques, integrated approaches and phase-appropriate development strategies.
Learning Points:
• What is a suitable screening package for determining the physical properties of an API and what are the red-flags to watch out for?
• How can the developability classification system (DCS) be used to streamline my formulation development program?
• How will in-vitro testing and pre-clinical evaluation help me guide the clinical formulation?
• Will a pre-clinical formulation be suitable for clinical use?
• Could a simple pharmacy preparation be suitable for my FIH trial or will a manufactured dosage form be required?
• How can we bridge from pharmacy preparations to GMP solid oral dosage forms that will be robust and scalable?
• How can you avoid common development pitfalls and ensure future success?
To register please click here.